Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: J Electrocardiol. 2018 Jul 30;51(6):997–1002. doi: 10.1016/j.jelectrocard.2018.07.027

Table 1.

Characteristics of MESA study participants with ECG patch monitoring

Characteristic Analysis 1: ≥ 12 days of
analyzable time
n=946
Analysis 2: ≥ 2 days
of analyzable time on
each of 2 monitors
n=439
Age at monitoring, yrs, N (%)
 57–69 320 (33.8) 150 (34.2)
 70–79 322 (34.0) 149 (33.9)
 80–89 278 (29.4) 127 (28.9)
 90–99 26 (2.8) 13 (3.0)
Race/ethnicity, N (%)
 White 409 (43.2) 229 (52.2)
 African American 208 (22.0) 88 (20.0)
 Hispanic 208(22.0) 69 (15.7)
 Chinese 121 (12.8) 53 (12.1)
Male sex, N (%) 487 (51.5) 219 (49.9)
Current smoking, N (%)* 71 (7.5) 32 (7.3)
Treated hypertension, N (%)* 513 (54.2) 239 (54.4)
Systolic blood pressure, mmHg, mean (SD)* 121.1 (19.1) 121.4 (19.6)
Diastolic blood pressure, mmHg, mean (SD)* 68.2 (10.1) 68.8 (10.0)
Body mass index, kg/m2, mean (SD) 28.4 (5.1) 28.4 (5.2)
Diabetes, N (%)* 166 (17.6%) 69 (15.7)
History of myocardial infarction, N (%)* 26 (2.8) 13 (3.0)
History of heart failure, N (%)* 21 (2.2) 9 (2.0)
History of clinically-recognized AF or atrial
 flutter, N (%)
142 (15.0) 69 (15.7)
*

Assessed at the 2010–2012 MESA exam